Tissue-Resident Macrophages in Cardiovascular Diseases: Heterogeneity and Therapeutic Potential
International Journal of Molecular Sciences · 09.05.2025 · 26 (10) · 4524
DOI: 10.3390/ijms26104524 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 09.05.2025. Verfasst von Tianhui An und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Geriatrics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China. Hauptthemen laut MEDLINE: Macrophages, Cardiovascular Diseases. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Tissue-resident macrophages (TRMs) play a crucial role in maintaining tissue homeostasis and regulating immune responses. In recent years, an increasing number of studies have highlighted their central role in cardiovascular diseases. This review provides a comprehensive overview of TRMs, with a particular emphasis on cardiac resident macrophages (CRMs), discussing their origin, heterogeneity, and functions in various cardiovascular diseases. We conduct an in-depth analysis of macrophage subpopulations based on C-C Chemokine Receptor Type 2 (CCR2) receptor expression, elucidating the role of CCR2+ macrophages in promoting fibrosis and cardiac remodeling, while highlighting the protective functions of CCR2− macrophages in suppressing inflammation and promoting tissue repair. In atherosclerosis, we focus on the role of metabolic reprogramming in regulating macrophage polarization, revealing how metabolic pathways influence the balance between pro-inflammatory M1 and anti-inflammatory M2 macrophages, thereby affecting plaque stability and disease progression. By summarizing the roles of these macrophage subpopulations in myocardial infarction, heart failure, and other diseases, we propose potential therapeutic strategies aimed at modulating different macrophage subtypes. These include targeting the CCR2 signaling pathway to mitigate inflammation and fibrosis, and metabolic reprogramming to restore the balance between M1 and M2 macrophages. Finally, we highlight the need for future research to focus on the functional diversity and molecular mechanisms of human TRMs to develop novel immunotherapeutic strategies and improve the prognosis of cardiovascular diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Geriatrics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
- Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
An, T., Guo, M., Wang, Z., & Liu, K. (2025). Tissue-Resident Macrophages in Cardiovascular Diseases: Heterogeneity and Therapeutic Potential. International Journal of Molecular Sciences, 26(10), 4524. https://doi.org/10.3390/ijms26104524
Vancouver
An T, Guo M, Wang Z, Liu K. Tissue-Resident Macrophages in Cardiovascular Diseases: Heterogeneity and Therapeutic Potential. International Journal of Molecular Sciences. 2025;26(10):4524. doi:10.3390/ijms26104524
BibTeX
@article{An2025,
author = {An, Tianhui and Guo, Mengyuan and Wang, Zhaohui and Liu, Kun},
title = {Tissue-Resident Macrophages in Cardiovascular Diseases: Heterogeneity and Therapeutic Potential},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {10},
pages = {4524},
doi = {10.3390/ijms26104524}
}
EUVIMED